Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-25Clinical Trial Update: Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
The pancreatic cancer risk model and biomarker testing trial (NCT05287347) in a high-risk cohort has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update covers Nano-SMART, a nanoparticle therapy with MR-guided SBRT being studied in centrally located lung tumors and …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
A Cedars-Sinai trial is studying small intestinal bacterial overgrowth in pancreatic adenocarcinoma patients, and it is currently recruiting…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
This entry reports an ongoing Phase 1/2 clinical trial evaluating the combination of avelumab and pepinemab as second-line therapy for metas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery [NA]
This clinical trial aims to evaluate high-volume washing of the abdomen during surgery to improve survival in patients with resectable pancr…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer [Phase 1]
A Phase 1 study of armed, activated T-cells for advanced pancreatic cancer is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating sequential AG regimen (nab-paclitaxel + gemcitabine) followed by modified FOLFIRINOX as neoadjuvant chemotherapy fo…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Predicting Effective Therapy in Pancreatic Cancer
A Memorial Sloan Kettering Cancer Center-led clinical trial aiming to predict effective therapies for pancreatic cancer is currently active …
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Activation of Biobank Registry for Bilio-pancreatic Diseases
A biobank registry for biliopancreatic diseases has been activated and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas [Phase 1]
Phase 1 trial assessing whether Onivyde manufactured at two production sites is equivalent in safety and pharmacokinetics for adults with me…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer [Phase 2]
Clinical trial update on a Phase 2 study evaluating nab-paclitaxel and gemcitabine with or without VCN-01 in metastatic pancreatic cancer; t…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 multi-center trial evaluating multiple regimens for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) [Phase 1]
Phase 1 clinical trial SHAPER investigates losartan with hypofractionated radiotherapy after chemotherapy for Borderline Resectable or Local…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation [Phase 1]
Phase 1 study of MRTX1133 in KRAS G12D-mutant solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: 68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma [NA]
Clinical trial update describing the imaging agent 68Ga-FAPI-46 for staging pancreatic adenocarcinoma, with the study not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
The INTER-Regional COHORTE study of long-term pancreatic cancer survivors has completed.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma
This clinical trial update describes a study investigating the impact of perioperative nutritional status and its management on outcomes in …
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Prognostic and Predictive Markers of Treatment Response in Patients With PAC.
This clinical trial update describes a study on prognostic and predictive markers of treatment response in patients with pancreatic adenocar…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr [Phase 2]
Phase 2 trial evaluating tailored decitabine repurposing for KRAS-dependent refractory pancreatic cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating sotorasib in combination with first-line chemotherapy for advanced pancreatic adenocarcinoma; the stu…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors [Phase 2]
Phase 2 study evaluating the efficacy of tislelizumab and spartalizumab across multiple cancers with PD-1 high mRNA expression; the trial is…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Biological and Clinical Database for Pancreatic Adenocarcinoma
A clinical trial update for a biological and clinical database in pancreatic adenocarcinoma; the study is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: SERum-bank for PANcreatic Cancer
This entry describes a serum-bank study for pancreatic cancer that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride and cisplatin with or without veliparib, or veliparib alone, in locally advanced…